Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
NYSE:PBH
Price:
70.39 USD
0.1%
Market Closed
Updated:
May 13, 2024
Prestige Consumer Healthcare Inc
Other Equity
|
Prestige Consumer Healthcare Inc
Other Equity Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Other Equity
-$28.5m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-33%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Equity
-$10.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-15%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Equity
-$1.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
12%
|
CAGR 10-Years
5%
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Equity
-$8B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-8%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Equity
-$5.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-9%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Equity
-$4.3B
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-7%
|
See Also
What is Prestige Consumer Healthcare Inc's Other Equity?
Other Equity
-28.5m
USD
-28.5m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Other Equity amounts to -28.5m USD.
What is Prestige Consumer Healthcare Inc's Other Equity growth rate?
Other Equity CAGR 10Y
-33%
-33%
Over the last year, the Other Equity growth was 3%. The average annual Other Equity growth rates for Prestige Consumer Healthcare Inc have been -25% over the past three years , -1% over the past five years , and -33% over the past ten years .
You don't have any saved screeners yet
